Skip to content
Search

Latest Stories

Flu vaccination: NICE quality standard recommends pharmacists to notify GPs on time

The National Institute for Health and Care Excellence (NICE) has published a new quality standard that covers increasing the uptake of flu vaccination among eligible people.

The first statement from the quality standard suggests the provider to use a range of different methods, including letter, email, phone and social media, to invite people from eligible groups for flu vaccination.


The quality standard recommends non-general practice providers, such as pharmacists, to notify the relevant GP practice when vaccinating their eligible patients.

“Timely, accurate and consistent recording of vaccination status in health records improves the accuracy of uptake figures and reduces unnecessary invites to people who have already had the vaccine,” the NICE statement read.

"Agreeing notification arrangements between commissioners and non-general practice providers means that GP practices receive information when their patients are vaccinated and allows them to maintain accurate records."

In case of a lower vaccine uptake, the quality standards advise to give information tailored to patients’ situation or clinical risk.

It further suggests health and social care staff who have direct contact with people to receive vaccination so that the risk of transmission of flu to vulnerable people will be reduced.

In October 2019, pharmacies and GP practices in Leeds participated in a first of its kind pilot by NHS Digital that enables sharing of flu vaccination details through clinical systems.

According to the latest flu vaccination data, published by the Pharmaceutical Services Negotiating Committee (PSNC), community pharmacists across England have administrated a total of 1,490,992 flu vaccinations under the NHS Flu Vaccination Service in the last four months.

More For You

Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less